Lupin gets 3 observations from USFDA for its Tarapur facility

The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VecWES
via IFTTT